• Home  HOME
  • About  ABOUT US
  • About  PRODUCTS
  • Research  RESEARCH
  • Investors  INVESTOR RELATIONS
  • Contact  CONTACT
  • AFFILIATED WEBSITES
  • Contact
  •  ABOUT US
  • History
  •  PRODUCTS
  • USA
  • Canada
  • Israel
  • International
  •  INVESTOR RELATIONS
  • Investor Relations
  • Financials
  • Annual Reports
  • Fundamentals
  • Earnings & Proxy Reports
  • News Releases
  • Investor FAQ
  • E-mail Alerts
  • Contact Information
  • Safe Harbor
  • AFFILIATED WEBSITES
  • Taro Pharmaceutical Industries Ltd. Taro U.S.A
  • Taro Canada Taro Canada
  • Taro Israel Taro Israel
  • Taro International Taro International
  • Sun Pharmaceutical Ind. Ltd
  • Sun Pharmaceutical USA
  • Chattem Chemicals Inc.
Skip to main content

Taro Pharmaceutical Industries

  • WORLDWIDE SITES
      • USA
      • Canada
      • Israel
      • International
Text Size A A A

Erik Zwicker

Print Home » Erik Zwicker
Submitted by admin on Tue, 08/02/2022 - 10:27

Erik Zwicker, J.D., joined our Company in April 2020 as Vice President, General Counsel and Secretary. He is currently responsible for the Company’s global legal function. Prior to joining Taro, Mr. Zwicker was Head of Legal and Chief Compliance Officer at Roivant Sciences, Inc., a global pharmaceutical company. Prior to Roivant, Mr. Zwicker was Deputy Chief Governance Officer at Bridgewater Associates, LP. In addition, Mr. Zwicker’s experience includes serving as an Assistant U.S. Attorney in the United States Attorney’s Office for the District of Columbia and as an Assistant Attorney General in the Connecticut Attorney General’s Office, and in private practice at a leading law firm. He has also penned various publications in the field of law. Mr. Zwicker holds a Bachelor of Arts degree from Princeton University, a Masters of Bioethics degree, which he earned while on a Fulbright Scholarship at Monash University in Melbourne, Australia, and a J.D. from Harvard Law School.

Image: 
Designation: 
Vice President, General Counsel and Secretary
order: 
2.2
  • Log in or register to post comments

Copyright © Taro Pharmaceutical Industries Ltd.  

Privacy Statement |  Terms of Use
Sitemap |  Site Credits